Pharos raised an oversubscribed $5M seed funding round

Pharos is looking to support healthcare institutions in areas like reducing preventable harm, automating reporting to clinical registries, and evaluating the impact of quality improvement projects by bringing AI to quality teams within those institutions. The startup recently secured $5 million in an oversubscribed seed funding round led by Felicis Ventures, and supported by General Catalyst, Y Combinator and Moxxie, who led Pharos' pre-seed round.

Pharos' founding team brings together CEO Felix Brann, CTO Matthew Jones, and Head of Research Dr. Alex Clarke. Brann and Jones met at Vital, where they deployed predictive AI across more than 70 hospitals. It is during their time at Vital that both realized the potential benefits AI could bring to hospitals' quality teams. During his time as VP of Data Science at Vital, Felix Brann published papers on sepsis prediction and medical record summarization using AI. Before joining Vital, Matthew Jones worked on the Orion Health EHR.

Their experience in healthcare and AI is complemented by Dr. Alex Clarke, who experienced the time-consuming nature of medical reporting during his residency, and worked as a medical AI researcher at Meta after completing a PhD in artificial intelligence from Imperial College London.